Log in or Sign up for Free to view tailored content for your specialty!
Gastropsychology News
IBS Awareness Month: Diagnostic tips, treatment options, multidisciplinary care and more
April is IBS Awareness Month and highlights the importance of public awareness and health messages about the diagnosis, treatment and quality of life for patients with irritable bowel syndrome.
VIDEO: Key aspects of treating, managing hospitalized IBD patients
NAPLES, Florida — In this video, Asad Ur Rahman, MD, a gastroenterologist at Cleveland Clinic Florida, spoke with Healio about key takeaways from his 2022 ACG/FGS Spring Symposium presentation on hospitalization in patients with severe IBD.
Log in or Sign up for Free to view tailored content for your specialty!
VIDEO: Janssen launches ‘UnstoppaBOLD’ campaign to help empower IBD patients
In this Healio video exclusive, Tara Muzsi, vice president of sales and marketing for gastroenterology at Janssen Pharmaceuticals, discusses the company’s Stelara UnstoppaBOLD 2.0 campaign for patients with inflammatory bowel disease.
VIDEO: Physicians must provide guidance for patients seeking alternative IBD therapies
NAPLES, Florida — In this video, Jennifer L. Seminerio, MD, stresses the importance of medical professionals “arming themselves with information” about alternative therapies, a topic she presented at the 2022 ACG/FGS Spring Symposium.
VIDEO: Interdisciplinary care model improves psychosocial disease outcomes in IBD
Preliminary data from the COMPASS-IBD study showed an interdisciplinary care model improved psychosocial outcome values among patients with inflammatory bowel disease.
VIDEO: IBD-related mental illness is ‘rarely discussed’ due to cultural stigmas
In this Healio video series, which focuses on cultural competency in the treatment of inflammatory bowel disease, Sharan Khela, an IBD patient advocate who has Crohn’s disease, shares her story and cultural stigmas she has had to overcome.
The future of IBS care relies on a multidisciplinary, integrative ‘team sport’ approach
According to the International Foundation for Gastrointestinal Disorders, irritable bowel syndrome is estimated to effect 10% to 15% of the population worldwide, making it the most prevalent functional GI disorder.
‘It takes a village’ to manage IBS
This month’s cover story focuses on the integrated, team-based approach to managing patients with irritable bowel syndrome.
New study details burden for caregivers of children with rare liver disease
Albireo Pharma Inc. announced the publication of the PICTURE study, which assessed the impact that progressive familial intrahepatic cholestasis has on caregivers, according to a company press release.
Q&A: Conquer communication disconnect to elevate IBD patient care
Results from a new survey published in Inflammatory Bowel Diseases highlight the need for improved communication between physicians and patients regarding IBD treatment goals and expectations.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read